Rivastigmine Tartrate drug description, Exporters, Importers, drug description, drugs Suppliers, Uses, Generic Products, Distributors, Side Effects, bulk drugs, Molecular Formula C14H22N2O2.C4H6O6, Molecular Weight 400.43,CAS Registry Number 129101-54-8, Anti-Bacterial, Warnings, Rivastigmine Tartrate Distributors, api, active pharmaceuticals ingredients, Information Drugs, Importers, drug Technology, FDA, Rivastigmine Tartrate, Taj Pharmaceuticals LTd.

Sitemap | Contact Us

Welcome To Taj Pharmaceuticals Ltd API

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved

Rivastigmine tartrate

India

Latin America/ Caribbean

Africa & Middle East

Asia

Russia

Europe

Rivastigmine Tartrate Manufacturers in India Suppliers Rivastigmine Tartrate Exporters Distributors Rivastigmine Tartrate api active pharmaceuticals ingredients Rivastigmine Tartrate manufacturers Side Effects bulk drugs raw material Rivastigmine Tartrate companies Side Effects Importers Rivastigmine Tartrate Rivastigmine Tartrate Exporters Rivastigmine Tartrate exporters FDA Rivastigmine Tartrate DMF Symptoms Generic Taj Pharmaceuticals Ltd.

active pharmaceutical ingredients suppliers pharmaceutical Rivastigmine Tartrate manufacturing pharmaceutical drugs pharmaceutical intermediates Rivastigmine Tartrate pharmaceutical chemicals pharmaceutical raw materials Rivastigmine Tartrate active pharmaceutical ingredients Rivastigmine Tartrate committee active pharmaceutical ingredients manufacturer Rivastigmine Tartrate Active Pharmaceutical Ingredients manufacturer Rivastigmine Tartrate exporter drug ingredients pharmaceuticals

Pharmaceuticals API Manufacturer Rivastigmine Tartrate, Rivastigmine Tartrate manufacturer India, Rivastigmine Tartrate product, Rivastigmine Tartrate products, Api preparation, Certificate of Analysis API manufacturer product, Rivastigmine Tartrate anti ulcer product, Certificate of Origin COA Rivastigmine Tartrate COS Rivastigmine Tartrate, pharmaceutical generic, pharmaceutical drug, medical, Rivastigmine Tartrate pharma healthcare, pharma patents, contract MSDS manufacturing Trader Rivastigmine Tartrate pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Rivastigmine Tartrate expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Rivastigmine Tartrate DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Rivastigmine Tartrate ingredients, api, HIV Rivastigmine Tartrate, tablets, capsules, syrup & protein Rivastigmine Tartrate powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Rivastigmine Tartrate gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Rivastigmine Tartrate WHO, UKMHRA Approval

	PRODUCT LIST
	Home
	API >>>
	Pharmaceuticals API List
	Chemicals
	Manufacturing
	Product Development
	Product Search
	Agro Chemicals
	Custom Pharma Services
	Contact Us

manufacturing machine

HOME >> API >> API List 3 >> Rivastigmine Tartrate >> Drug Description

DRUG DESCRIPTION
Rivastigmine Tartrate CAS Registry Number 129101-54-8

Rivastigmine Tartrate (rivastigmine tartrate) is a reversible cholinesterase inhibitor and is known chemically as (S)-N-Ethyl-N-methyl-3-[1-(dimethylamino)ethyl]-phenyl carbamate hydrogen-(2R,3R)-tartrate. Rivastigmine tartrate is commonly referred to in the pharmacological literature as SDZ ENA 713 or ENA 713. It has an empirical formula of C14H22N2O2•C4H6O6 (hydrogen tartrate salt - hta salt) and a molecular weight of 400.43 (hta salt). Rivastigmine tartrate is a white to off-white, fine crystalline powder that is very soluble in water, soluble in ethanol and acetonitrile, slightly soluble in n-octanol and very slightly soluble in ethyl acetate. The distribution coefficient at 37°C in n- octanol/phosphate buffer solution pH 7 is 3.0.rivastigmine tartrate, equivalent to 1.5, 3, 4.5 and 6 mg of rivastigmine base for oral administration. Inactive ingredients are hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose, and silicon dioxide. Each hard-gelatin capsule contains gelatin, titanium dioxide and red and/or yellow iron oxides.

Rivastigmine Tartrate is used in the treatment of mild to moderate Alzheimer's disease. Alzheimer's disease causes physical changes in the brain that disrupt the flow of information and interfere with memory, thinking, and behavior. By boosting levels of the chemical messenger acetylcholine, Rivastigmine Tartrate can temporarily improve brain function in some Alzheimer's sufferers, though it does not halt the progress of the underlying disease. Rivastigmine Tartrate may become less effective as the disease progresses.

Information Associated with Product:

DRUG DESCRIPTION >>

DOSAGE

SIDE EFFECTS

PRECAUTIONS

INTERACTION

CONSUMER INFORMATION

PDF DOWNLOAD

WORD DOCUMENT


Product Enquiry	Product Quotation	Sample Request	Place Your Order

Taj Pharmaceuticals API Logo

Investor Relations Feedback Contact Worldwide Sitemap

© 2004 - 2019 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Limited products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.